Laurion Capital Management LP Vertex Pharmaceuticals Inc Put Options Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $5.53 Million - $6.17 Million	20,200 New	20,200 $5.85 Million
Q4 2019 Feb 13, 2020	SELL	$166.71 - $223.91 $3.33 Million - $4.48 Million	-20,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$166.23 - $187.09 $3.32 Million - $3.74 Million	20,000 New	20,000 $3.39 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $1 Million - $1.27 Million	-6,600 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $1.11 Million - $1.27 Million	6,600 New	6,600 $1.27 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.